HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

albuferon

to improve the pharmacokinetics of IFN-alpha and decrease dosing frequency, IFN-alpha was fused to human serum albumin producing albuferon

Also Known As:

albuferon-alpha

Networked: 2 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Kratz, Felix: 1 article (12/2008)
2.	Chemmanur, Annie T: 1 article (08/2006)
3.	Wu, George Y: 1 article (08/2006)

Related Diseases

1.	Infections 08/01/2006 - "By May 2004, phase II clinical trials of Albuferon in HCV infection were underway. " 08/01/2006 - "Human Genome Sciences Inc (HGS), in collaboration with Novartis AG, is developing Albuferon-alpha, a long-acting injectable human interferon alpha2b fusion protein, for the potential treatment of hepatitis C virus (HCV) infection. "
2.	Hepatitis C 12/18/2008 - "Furthermore, Albuferon, a fusion protein of albumin and interferon, is currently being assessed in phase III clinical trials for the treatment of hepatitis C and could become an alternative to pegylated interferon. "
3.	Neoplasms (Cancer) 08/01/2006 - "Albuferon also has the potential to treat a broad range of cancers."

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)
2.	Interferons
3.	Albumins

Related Therapies and Procedures

1.	Injections